the Effect of Minimally Invasive Technique Assisted by Magnetic Resonance Neurography
Launched by HE XIANG · Feb 13, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new approach to treating gluteal muscle contracture (GMC), a condition that can cause tightness and discomfort in the muscles of the buttocks. The researchers want to see if a special imaging technique called magnetic resonance neurography (MRN) can improve the outcomes of a minimally invasive surgery. In this study, one group of patients will have their surgery guided by MRN to tailor the surgical approach based on their specific imaging results, while another group will have surgery without this guidance. The main goal is to determine if the MRN-assisted surgery leads to better recovery and less pain after the procedure.
To be eligible for this trial, participants should be between 18 and 65 years old, have moderate to severe GMC that hasn't improved with at least six months of other treatments, and be willing to undergo surgery and follow-up appointments. Participants can expect to undergo a preoperative MRI scan, followed by their assigned surgical approach. Throughout the study, the team will monitor how well the surgery works and any complications that may arise. This trial is currently recruiting patients who meet these criteria, and they are looking for individuals who can commit to the process and provide informed consent.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria:
- • (1). Meet the clinical and imaging diagnostic criteria of GMC ; (2).According to Zhao \'s classification system, patients with moderate to severe GMC diagnosed by medical history, symptoms and physical examination ; (3).Conservative treatment is ineffective for at least 6 months, and daily life is significantly affected ; (4).willing to be hospitalized and receive minimally invasive surgery ; (5). Can cooperate to complete the follow-up ; (6).Patients or immediate family members signed informed consent ; (7). Age 18-65 years old
- Exclusion Criteria:
- • 1. . There is clinical or imaging evidence that there is or may be spinal or lower extremity neurological disease ;
- • 2. . There is evidence of hip dysplasia or subluxation ;
- • 3. .after evaluation of intolerance to surgical anesthesia ;
- • 4. .coagulant dysfunction ;
- • 5. . unable to complete the follow-up for various reasons ;
- • 6. . Patients can not complete the scale assessment for other reasons
About He Xiang
He Xiang is a dedicated clinical trial sponsor focused on advancing innovative therapeutic solutions through rigorous research and development. Committed to improving patient outcomes, He Xiang collaborates with a network of leading healthcare professionals and institutions to conduct high-quality clinical trials across various therapeutic areas. With a strong emphasis on ethical practices and regulatory compliance, the organization strives to ensure the safety and efficacy of new treatments while fostering transparency and integrity in all aspects of the clinical research process. Through its initiatives, He Xiang aims to contribute significantly to the global medical landscape and enhance the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Xian, Shaanxi, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported